Lv21
140 积分 2025-10-10 加入
Clinical phenotypes, autoimmunity and outcomes in Rosai–Dorfman disease: An international multicentre cohort study
20分钟前
已完结
Engineering viral vectors for in vivo CAR-T generation: Advances, challenges, and opportunities
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
2个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
5个月前
已完结
Genome-Wide Screens Reveal Potential Biomarkers of NK-cell Sensitivity
8个月前
已完结
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
11个月前
已完结
Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma
1年前
已完结